Prevalence and Clinical Implications of Minority Variant (MV) Human Immunodeficiency Virus (HIV) Drug-Resistance Mutations (DRMs) in Antiretroviral (ARV)-Naive Patients With and Without Transmitted Drug Resistance (TDR)